Table 1.
Peptide Length | Sequence Delete from N-term |
Activity, nmol/min/mg Prot. | Sequence Delete from C-term |
Activity, nmol/min/mg Prot. |
---|---|---|---|---|
control | No peptide | 94.8 | Scrambled peptide: LELDEEITEYQKQLHI |
93.5 |
16 aa | DEELQTELYEIKHQIL | 32.0 | DEELQTELYEIKHQIL | 32.0 |
14 aa | ELQTELYEIKHQIL | 33.2 | DEELQTELYEIKHQ | 102 |
12 aa | QTELYEIKHQIL | 31.5 | No entry | |
10 aa | ELYEIKHQIL | 28.6 | No entry | |
9 aa | LYEIKHQIL (PIP-1) |
32.3 | ELYEIKHQI | 89.6 |
8 aa | YEIKHQIL | 94.4 | DEELQTEL | 93.6 |
Sequential deletions from the N-terminus or C-terminus of the rat/mouse 16-aa inhibitory peptide were used to determine the minimal effective sequence to inhibit the aiPLA2 activity of peroxiredoxin 6 (Prdx6). The results represent one assay done in duplicate.